Global Non-insulin Diabetes Therapeutics Market Professional Survey Report 2021

Table of Contents

Global Non-insulin Diabetes Therapeutics Market Professional Survey Report 2021
1 Industry Overview of Non-insulin Diabetes Therapeutics
1.1 Definition and Specifications of Non-insulin Diabetes Therapeutics
1.1.1 Definition of Non-insulin Diabetes Therapeutics
1.1.2 Specifications of Non-insulin Diabetes Therapeutics
1.2 Classification of Non-insulin Diabetes Therapeutics
1.2.1 Alpha-glucosidase Inhibitors
1.2.2 Amylin Agonists
1.2.3 Biguanides
1.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
1.2.5 Glinides / Meglitinides
1.2.6 GLP-1 Analogs / GLP-1 Agonists
1.2.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
1.2.8 Sulfonylureas
1.2.9 Thiazolidinediones
1.2.10 Others
1.3 Applications of Non-insulin Diabetes Therapeutics
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacy
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Non-insulin Diabetes Therapeutics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-insulin Diabetes Therapeutics
2.3 Manufacturing Process Analysis of Non-insulin Diabetes Therapeutics
2.4 Industry Chain Structure of Non-insulin Diabetes Therapeutics

3 Technical Data and Manufacturing Plants Analysis of Non-insulin Diabetes Therapeutics
3.1 Capacity and Commercial Production Date of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017

4 Global Non-insulin Diabetes Therapeutics Overall Market Overview
4.1 2016-2021E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2016-2021E Global Non-insulin Diabetes Therapeutics Capacity and Growth Rate Analysis
4.2.2 2017 Non-insulin Diabetes Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2016-2021E Global Non-insulin Diabetes Therapeutics Sales and Growth Rate Analysis
4.3.2 2017 Non-insulin Diabetes Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2016-2021E Global Non-insulin Diabetes Therapeutics Sales Price
4.4.2 2017 Non-insulin Diabetes Therapeutics Sales Price Analysis (Company Segment)

5 Non-insulin Diabetes Therapeutics Regional Market Analysis
5.1 North America Non-insulin Diabetes Therapeutics Market Analysis
5.1.1 North America Non-insulin Diabetes Therapeutics Market Overview
5.1.2 North America 2016-2021E Non-insulin Diabetes Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2016-2021E Non-insulin Diabetes Therapeutics Sales Price Analysis
5.1.4 North America 2017 Non-insulin Diabetes Therapeutics Market Share Analysis
5.2 China Non-insulin Diabetes Therapeutics Market Analysis
5.2.1 China Non-insulin Diabetes Therapeutics Market Overview
5.2.2 China 2016-2021E Non-insulin Diabetes Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2016-2021E Non-insulin Diabetes Therapeutics Sales Price Analysis
5.2.4 China 2017 Non-insulin Diabetes Therapeutics Market Share Analysis
5.3 Europe Non-insulin Diabetes Therapeutics Market Analysis
5.3.1 Europe Non-insulin Diabetes Therapeutics Market Overview
5.3.2 Europe 2016-2021E Non-insulin Diabetes Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2016-2021E Non-insulin Diabetes Therapeutics Sales Price Analysis
5.3.4 Europe 2017 Non-insulin Diabetes Therapeutics Market Share Analysis
5.4 Southeast Asia Non-insulin Diabetes Therapeutics Market Analysis
5.4.1 Southeast Asia Non-insulin Diabetes Therapeutics Market Overview
5.4.2 Southeast Asia 2016-2021E Non-insulin Diabetes Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2016-2021E Non-insulin Diabetes Therapeutics Sales Price Analysis
5.4.4 Southeast Asia 2017 Non-insulin Diabetes Therapeutics Market Share Analysis
5.5 Japan Non-insulin Diabetes Therapeutics Market Analysis
5.5.1 Japan Non-insulin Diabetes Therapeutics Market Overview
5.5.2 Japan 2016-2021E Non-insulin Diabetes Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2016-2021E Non-insulin Diabetes Therapeutics Sales Price Analysis
5.5.4 Japan 2017 Non-insulin Diabetes Therapeutics Market Share Analysis
5.6 India Non-insulin Diabetes Therapeutics Market Analysis
5.6.1 India Non-insulin Diabetes Therapeutics Market Overview
5.6.2 India 2016-2021E Non-insulin Diabetes Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2016-2021E Non-insulin Diabetes Therapeutics Sales Price Analysis
5.6.4 India 2017 Non-insulin Diabetes Therapeutics Market Share Analysis

6 Global 2016-2021E Non-insulin Diabetes Therapeutics Segment Market Analysis (by Type)
6.1 Global 2016-2021E Non-insulin Diabetes Therapeutics Sales by Type
6.2 Different Types of Non-insulin Diabetes Therapeutics Product Interview Price Analysis
6.3 Different Types of Non-insulin Diabetes Therapeutics Product Driving Factors Analysis
6.3.1 Alpha-glucosidase Inhibitors of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.2 Amylin Agonists of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.3 Biguanides of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.5 Glinides / Meglitinides of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.6 GLP-1 Analogs / GLP-1 Agonists of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.8 Sulfonylureas of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.9 Thiazolidinediones of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
6.3.10 Others of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis

7 Global 2016-2021E Non-insulin Diabetes Therapeutics Segment Market Analysis (by Application)
7.1 Global 2016-2021E Non-insulin Diabetes Therapeutics Consumption by Application
7.2 Different Application of Non-insulin Diabetes Therapeutics Product Interview Price Analysis
7.3 Different Application of Non-insulin Diabetes Therapeutics Product Driving Factors Analysis
7.3.1 Hospital Pharmacy of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
7.3.2 Retail Pharmacies of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
7.3.3 Online Pharmacy of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis
7.3.4 Others of Non-insulin Diabetes Therapeutics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Non-insulin Diabetes Therapeutics
8.1 GSK
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 GSK 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 GSK 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.2 Eli Lilly
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Eli Lilly 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eli Lilly 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.3 Sumitomo Dainippon Pharma
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Sumitomo Dainippon Pharma 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Sumitomo Dainippon Pharma 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.4 Intarcia Therapeutics
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Intarcia Therapeutics 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Intarcia Therapeutics 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.5 Servier
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Servier 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Servier 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.6 Jiangsu Hansoh Pharmaceutical
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Jiangsu Hansoh Pharmaceutical 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Jiangsu Hansoh Pharmaceutical 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.7 Novo Nordisk
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Novo Nordisk 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novo Nordisk 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.8 Emisphere
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Emisphere 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Emisphere 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.9 Uni-Bio Science Group
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Uni-Bio Science Group 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Uni-Bio Science Group 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.10 Takeda
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Takeda 2017 Non-insulin Diabetes Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Takeda 2017 Non-insulin Diabetes Therapeutics Business Region Distribution Analysis
8.11 3SBio
8.12 Merck
8.13 Dong-A Pharmaceutical
8.14 Luye Pharma Group
8.15 Eurofarma
8.16 Geropharm
8.17 Alkem Labs
8.18 SatRx
8.19 Pfizer
8.20 Jiangsu Hengrui Medicine

9 Development Trend of Analysis of Non-insulin Diabetes Therapeutics Market
9.1 Global Non-insulin Diabetes Therapeutics Market Trend Analysis
9.1.1 Global 2021-2027 Non-insulin Diabetes Therapeutics Market Size (Volume and Value) Forecast
9.1.2 Global 2021-2027 Non-insulin Diabetes Therapeutics Sales Price Forecast
9.2 Non-insulin Diabetes Therapeutics Regional Market Trend
9.2.1 North America 2021-2027 Non-insulin Diabetes Therapeutics Consumption Forecast
9.2.2 China 2021-2027 Non-insulin Diabetes Therapeutics Consumption Forecast
9.2.3 Europe 2021-2027 Non-insulin Diabetes Therapeutics Consumption Forecast
9.2.4 Southeast Asia 2021-2027 Non-insulin Diabetes Therapeutics Consumption Forecast
9.2.5 Japan 2021-2027 Non-insulin Diabetes Therapeutics Consumption Forecast
9.2.6 India 2021-2027 Non-insulin Diabetes Therapeutics Consumption Forecast
9.3 Non-insulin Diabetes Therapeutics Market Trend (Product Type)
9.4 Non-insulin Diabetes Therapeutics Market Trend (Application)

10 Non-insulin Diabetes Therapeutics Marketing Type Analysis
10.1 Non-insulin Diabetes Therapeutics Regional Marketing Type Analysis
10.2 Non-insulin Diabetes Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Non-insulin Diabetes Therapeutics by Region
10.4 Non-insulin Diabetes Therapeutics Supply Chain Analysis

11 Consumers Analysis of Non-insulin Diabetes Therapeutics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Non-insulin Diabetes Therapeutics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


List of Tables and Figures
Figure Picture of Non-insulin Diabetes Therapeutics
Table Product Specifications of Non-insulin Diabetes Therapeutics
Table Classification of Non-insulin Diabetes Therapeutics
Figure Global Production Market Share of Non-insulin Diabetes Therapeutics by Type in 2017
Figure Alpha-glucosidase Inhibitors Picture
Table Major Manufacturers of Alpha-glucosidase Inhibitors
Figure Amylin Agonists Picture
Table Major Manufacturers of Amylin Agonists
Figure Biguanides Picture
Table Major Manufacturers of Biguanides
Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Picture
Table Major Manufacturers of Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Figure Glinides / Meglitinides Picture
Table Major Manufacturers of Glinides / Meglitinides
Figure GLP-1 Analogs / GLP-1 Agonists Picture
Table Major Manufacturers of GLP-1 Analogs / GLP-1 Agonists
Figure Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Picture
Table Major Manufacturers of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Figure Sulfonylureas Picture
Table Major Manufacturers of Sulfonylureas
Figure Thiazolidinediones Picture
Table Major Manufacturers of Thiazolidinediones
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Non-insulin Diabetes Therapeutics
Figure Global Consumption Volume Market Share of Non-insulin Diabetes Therapeutics by Application in 2017
Figure Hospital Pharmacy Examples
Table Major Consumers in Hospital Pharmacy
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Online Pharmacy Examples
Table Major Consumers in Online Pharmacy
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Non-insulin Diabetes Therapeutics by Regions
Figure North America Non-insulin Diabetes Therapeutics Market Size (Million USD) (2016-2027)
Figure China Non-insulin Diabetes Therapeutics Market Size (Million USD) (2016-2027)
Figure Europe Non-insulin Diabetes Therapeutics Market Size (Million USD) (2016-2027)
Figure Southeast Asia Non-insulin Diabetes Therapeutics Market Size (Million USD) (2016-2027)
Figure Japan Non-insulin Diabetes Therapeutics Market Size (Million USD) (2016-2027)
Figure India Non-insulin Diabetes Therapeutics Market Size (Million USD) (2016-2027)
Table Non-insulin Diabetes Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-insulin Diabetes Therapeutics in 2017
Figure Manufacturing Process Analysis of Non-insulin Diabetes Therapeutics
Figure Industry Chain Structure of Non-insulin Diabetes Therapeutics
Table Capacity and Commercial Production Date of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Non-insulin Diabetes Therapeutics Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Non-insulin Diabetes Therapeutics 2016-2021E
Figure Global 2016-2021E Non-insulin Diabetes Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2016-2021E Non-insulin Diabetes Therapeutics Market Size (Value) and Growth Rate
Table 2016-2021E Global Non-insulin Diabetes Therapeutics Capacity and Growth Rate
Table 2017 Global Non-insulin Diabetes Therapeutics Capacity (K Units) List (Company Segment)
Table 2016-2021E Global Non-insulin Diabetes Therapeutics Sales (K Units) and Growth Rate
Table 2017 Global Non-insulin Diabetes Therapeutics Sales (K Units) List (Company Segment)
Table 2016-2021E Global Non-insulin Diabetes Therapeutics Sales Price (USD/Unit)
Table 2017 Global Non-insulin Diabetes Therapeutics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Non-insulin Diabetes Therapeutics 2016-2021E
Figure North America 2016-2021E Non-insulin Diabetes Therapeutics Sales Price (USD/Unit)
Figure North America 2017 Non-insulin Diabetes Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Non-insulin Diabetes Therapeutics 2016-2021E
Figure China 2016-2021E Non-insulin Diabetes Therapeutics Sales Price (USD/Unit)
Figure China 2017 Non-insulin Diabetes Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Non-insulin Diabetes Therapeutics 2016-2021E
Figure Europe 2016-2021E Non-insulin Diabetes Therapeutics Sales Price (USD/Unit)
Figure Europe 2017 Non-insulin Diabetes Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Non-insulin Diabetes Therapeutics 2016-2021E
Figure Southeast Asia 2016-2021E Non-insulin Diabetes Therapeutics Sales Price (USD/Unit)
Figure Southeast Asia 2017 Non-insulin Diabetes Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Non-insulin Diabetes Therapeutics 2016-2021E
Figure Japan 2016-2021E Non-insulin Diabetes Therapeutics Sales Price (USD/Unit)
Figure Japan 2017 Non-insulin Diabetes Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Non-insulin Diabetes Therapeutics 2016-2021E
Figure India 2016-2021E Non-insulin Diabetes Therapeutics Sales Price (USD/Unit)
Figure India 2017 Non-insulin Diabetes Therapeutics Sales Market Share
Table Global 2016-2021E Non-insulin Diabetes Therapeutics Sales (K Units) by Type
Table Different Types Non-insulin Diabetes Therapeutics Product Interview Price
Table Global 2016-2021E Non-insulin Diabetes Therapeutics Sales (K Units) by Application
Table Different Application Non-insulin Diabetes Therapeutics Pro

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.